Anil Chandraker to Cytokines
This is a "connection" page, showing publications Anil Chandraker has written about Cytokines.
Connection Strength
0.213
-
Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Transplantation. 2002 Jun 15; 73(11):1736-42.
Score: 0.037
-
Zhang H, Wang Z, Zhang J, Gui Z, Han Z, Tao J, Chen H, Sun L, Fei S, Yang H, Tan R, Chandraker A, Gu M. Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation. Front Immunol. 2021; 12:618737.
Score: 0.034
-
Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998 Jun 27; 65(12):1533-42.
Score: 0.028
-
Nadeau K, Azuma H, Chandraker A, Sayegh MH, Tilney NL. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):1038.
Score: 0.025
-
Onodera K, Hancock WW, Graser E, Volk HD, Lehmann M, Chandraker A, Sayegh MH, Kupiec-Weglinski JW. Th2-type cytokines in the "infectious" tolerance pathway. Transplant Proc. 1997 Feb-Mar; 29(1-2):1290-1.
Score: 0.025
-
Tsaur I, Gasser M, Aviles B, Lutz J, Lutz L, Grimm M, Lange V, Lopau K, Heemann U, Germer CT, Chandraker A, Waaga-Gasser AM. Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients. Kidney Int. 2011 May; 79(9):1005-12.
Score: 0.017
-
Imitola J, Comabella M, Chandraker AK, Dangond F, Sayegh MH, Snyder EY, Khoury SJ. Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. Am J Pathol. 2004 May; 164(5):1615-25.
Score: 0.011
-
Magee CC, Azuma H, Knoflach A, Denton MD, Chandraker A, Iyer S, Buelow R, Sayegh M. In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. J Am Soc Nephrol. 1999 Sep; 10(9):1997-2005.
Score: 0.008
-
Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Transplantation. 1999 Jul 27; 68(2):288-93.
Score: 0.008
-
Onodera K, Chandraker A, Kato H, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2. Transplant Proc. 1999 Feb-Mar; 31(1-2):876-7.
Score: 0.007
-
Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Transplantation. 1998 Oct 27; 66(8):1059-66.
Score: 0.007
-
Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol. 1995 Nov 15; 155(10):4521-4.
Score: 0.006